Glucosamine sulfate (Dona®)

Assessment Status Assessment process complete
HTA ID -
Drug Glucosamine sulfate
Brand Dona®
Indication For the treatment of oestoarthritis in the Irish Healthcare setting.
Assessment Process
Full pharmacoeconomic assessment commissioned by HSE 04/05/2009
NCPE assessment completed 01/06/2009
NCPE assessment outcome Reimbursement not recommended.